Showing results (71-80 of 185) with videos related to
Sort By:
Pageof 19
AIDS (London, England)|April 25, 2009
Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosisPriscilla Y Hsue, Peter W Hunt, Amanda Schnell, et al.AIDS (London, England)|June 15, 2010
Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individualsJennifer E Ho, Steven G Deeks, Frederick M Hecht, et al.The Journal of Sexual Medicine|June 23, 2009
Erectile dysfunction and mortalityAndre B Araujo, Thomas G Travison, Peter Ganz, et al.Circulation|December 4, 2002
Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cellsUwe Schönbeck, Norbert Gerdes, Nerea Varo, et al.Diabetes Care|June 13, 2020
Mechanisms of Sodium-Glucose Cotransporter 2 Inhibition: Insights From Large-Scale ProteomicsEle Ferrannini, Ashwin C Murthy, Yong-Ho Lee, et al.Journal of the American College of Cardiology|February 2, 2010
Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score?Andre B Araujo, Susan A Hall, Peter Ganz, et al.Circulation|September 17, 2003
High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL studyScott Kinlay, Gregory G Schwartz, Anders G Olsson, et al.The Journal of Sexual Medicine|February 13, 2009
Is hyperlipidemia or its treatment associated with erectile dysfunction?: Results from the Boston Area Community Health (BACH) SurveySusan A Hall, Varant Kupelian, Raymond C Rosen, et al.Circulation|October 5, 2017
Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of TorcetrapibStephen A Williams, Ashwin C Murthy, Robert K DeLisle, et al.European Heart Journal|March 15, 2005
High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trialAnders G Olsson, Gregory G Schwartz, Michael Szarek, et al.Pageof 19